274 related articles for article (PubMed ID: 11839674)
1. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
[TBL] [Abstract][Full Text] [Related]
2. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
4. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
[TBL] [Abstract][Full Text] [Related]
5. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma.
Cools D; Debiec-Rychter M; Parys-Van Ginderdeuren R; Hagemeijer-Hausman A; Van den Oord J; Spileers W
Bull Soc Belge Ophtalmol; 2000; (278):67-70. PubMed ID: 11761564
[TBL] [Abstract][Full Text] [Related]
8. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
[TBL] [Abstract][Full Text] [Related]
9. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
[TBL] [Abstract][Full Text] [Related]
11. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
12. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
[TBL] [Abstract][Full Text] [Related]
13. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
14. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 3 intratumor heterogeneity in uveal melanoma.
Mensink HW; Vaarwater J; Kiliç E; Naus NC; Mooy N; Luyten G; Brüggenwirth HT; Paridaens D; de Klein A
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):500-4. PubMed ID: 18824727
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
White JS; Becker RL; McLean IW; Director-Myska AE; Nath J
Cancer Genet Cytogenet; 2006 Jul; 168(1):11-21. PubMed ID: 16772116
[TBL] [Abstract][Full Text] [Related]
17. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.
Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189
[TBL] [Abstract][Full Text] [Related]
18. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
[TBL] [Abstract][Full Text] [Related]
19. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies.
Maat W; Jordanova ES; van Zelderen-Bhola SL; Barthen ER; Wessels HW; Schalij-Delfos NE; Jager MJ
Arch Pathol Lab Med; 2007 Jan; 131(1):91-6. PubMed ID: 17227129
[TBL] [Abstract][Full Text] [Related]
20. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
